Is Congenital Muscular Mitral-Aortic Discontinuity Another Feature of Obstructive Hypertrophic Cardiomyopathy? A

Monica De Gaspari1, Mariachiara Mazzucato1, Maria Bueno Marinas1

  • 1Department of Cardiac, Thoracic, Vascular Sciences and Public Health, University of Padua, Padua, Italy; Cardiovascular Pathology Unit, Azienda Ospedaliera, Padua, Italy.

Insights

Pathologic analysis of hypertrophic cardiomyopathy (HCM) hearts did not confirm a "muscular mitral-aortic discontinuity." Instead, an extension of left atrial myocardium was observed, decreasing with age.

Area of Science:

  • Cardiovascular Pathology
  • Cardiac Anatomy
  • Inherited Cardiac Diseases

Background:

  • Hypertrophic cardiomyopathy (HCM) is a genetic heart muscle disease associated with sudden cardiac death and heart failure.
  • Surgical observations in obstructive HCM have suggested a
  • muscular mitral-aortic discontinuity
  • .

Purpose of the Study:

  • To pathologically validate the existence of a
  • muscular mitral-aortic discontinuity
  • in hypertrophic cardiomyopathy (HCM).
  • To characterize the mitral-aortic continuity in HCM hearts through gross and histologic examination.

Main Methods:

  • Analysis of 30 HCM hearts and 30 age- and sex-matched controls from a cardiovascular pathology registry.
  • Gross and histologic examination of the mitral valve apparatus and mitral-aortic continuity.
  • Comparison of findings between HCM and control groups.

Main Results:

  • A myocardial layer overlapping the mitral-aortic fibrous continuity was present in 97% of HCM hearts, identified as left atrial myocardium.
  • Features such as septal bulging, endocardial fibrous plaque, and anterior mitral leaflet thickening were noted in HCM.
  • The length of the overlapping myocardial layer showed a negative correlation with age and anterior mitral leaflet length, but did not differ between HCM and controls.

Conclusions:

  • Pathologic findings do not support the existence of a
  • muscular mitral-aortic discontinuity
  • in obstructive HCM.
  • An extension of left atrial myocardium overlapping the intervalvular fibrosa is consistently observed.
  • The length of this myocardial extension decreases with age, potentially due to left atrial remodeling, emphasizing the importance of detailed gross examination.

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
17
Mitral Valve Prolapse I: Introduction01:27

Mitral Valve Prolapse I: Introduction

IntroductionThe mitral valve, one of the heart's four valves, regulates blood flow. These valves have flaps that open and close to direct blood properly through the heart and body. During each heartbeat, the flaps open for blood to pass through and seal shut to prevent backflow. Specifically, the mitral valve opens to allow blood flow from the heart's upper left chamber to the lower left chamber. It then closes securely as the lower left chamber contracts to pump blood to the body, preventing...
22
Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
25
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
18
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
22
Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
19